Category: Health

Novo Nordisk Logo

Gradual Addition of NovoLog® at Mealtime Can Reduce A1c in Type 2 Diabetes Patients

Novo Nordisk announced results of its STEPwise™ trial, which identified a method of intensifying insulin treatment with NovoLog® (insulin aspart [rDNA origin] injection). The study, presented at the American Diabetes Association (ADA) 2010 Scientific Sessions, demonstrated a reduction of A1c levels in type 2 diabetes patients when a dose of NovoLog® was introduced at meals, using two approaches that start with the largest meal of...
0 Shares

Eating and Thriving on a Restricted Diet

I was forced to innovate and try new things that I never would have considered eating -- boiled taro root, cassava, kale, collard greens, amaranth, and virtually any sort of meat, including once, kangaroo...
0 Shares

Hemoglobin A1c Levels Differ in Black and White Persons

A new study published in the Annals of Internal Medicine shows hemoglobin A1c levels differ in black and white persons independent of glucose levels. The study looked at 1581 non-Hispanic black and white persons in the Atlanta area between 18 and 87 years of age who did not have known diabetes...
0 Shares
diabetes-uk-logo

Type 2 Diabetes Increases Cancer Risk in Woman but Protects Men

Type 2 diabetes appears to reduce the risk of prostate cancer in men, but appears to increase the risk of some cancers in women, researchers in Israel said. Diabetes UK reports on a study led by Dr. Gabriel Chodick and Dr. Varda Shalev of Tel Aviv University's Sackler Faculty of Medicine. The study examined 16,721 people with diabetes and determined the relative
0 Shares

Beware of “Natural” Diabetes Cures

In an undercover probe, investigators at the Government Accountability Office found that labels for some supplements, like ginseng, echinacea and other herbal and dietary supplements, claim to prevent or cure ailments like diabetes or heart disease or even cancer, according to a Reuters report. These claims are a violation of U.S law...
0 Shares
Novartis

Novartis’ Ranibizumab More Effective Than Laser Treatment in Treating Vision Loss due to Diabetic Macular Edema

Novartis announced that first results of the RESTORE Phase III study show that ranibizumab is significantly more effective than laser treatment, the current standard of care, at treating visual impairment due to diabetic macular edema (DME), a serious complication of diabetes. The one year results show that 37% of patients treated with ranibizumab 0.5 mg alone, and 43% of those treated with ranibizumab...
0 Shares

Diabetes Drug Metformin Linked to Vitamin B 12 Deficiency

Diabetics treated over long periods with the drug metformin, one of the most commonly prescribed drugs for the treatment of diabetes, are at risk of developing vitamin B12 deficiency. This condition is likely to get worse over time, according to a study published in the British Medical Journal...
0 Shares